Literature DB >> 19595448

The unchanging mortality gap for people with schizophrenia.

Lydia A Chwastiak1, Cenk Tek.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19595448     DOI： 10.1016/S0140-6736(09)61072-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  15 in total

1.  WPA guidance on steps, obstacles and mistakes to avoid in the implementation of community mental health care.

Authors:  Graham Thornicroft; Atalay Alem; Renato Antunes Dos Santos; Elizabeth Barley; Robert E Drake; Guilherme Gregorio; Charlotte Hanlon; Hiroto Ito; Eric Latimer; Ann Law; Jair Mari; Peter McGeorge; Ramachandran Padmavati; Denise Razzouk; Maya Semrau; Yutaro Setoya; Rangaswamy Thara; Dawit Wondimagegn
Journal:  World Psychiatry       Date:  2010-06       Impact factor: 49.548

2.  Ketamine-induced behavioural and brain oxidative changes in mice: an assessment of possible beneficial effects of zinc as mono- or adjunct therapy.

Authors:  Olakunle James Onaolapo; Olayemi Quyyom Ademakinwa; Temitayo Opeyemi Olalekan; Adejoke Yetunde Onaolapo
Journal:  Psychopharmacology (Berl)       Date:  2017-06-14       Impact factor: 4.530

3.  Mortality of people suffering from mental illness: a study of a cohort of patients hospitalised in psychiatry in the north of France.

Authors:  Claire-Lise Charrel; Laurent Plancke; Michaël Genin; Laurent Defromont; François Ducrocq; Guillaume Vaiva; Thierry Danel
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-06-11       Impact factor: 4.328

4.  A Surveillance System to Monitor Excess Mortality of People With Mental Illness in Canada.

Authors:  Alain Lesage; Louis Rochette; Valérie Émond; Éric Pelletier; Danielle St-Laurent; Fatoumata Binta Diallo; Stephen Kisely
Journal:  Can J Psychiatry       Date:  2015-12       Impact factor: 4.356

Review 5.  Antipsychotic-induced weight gain in first-episode psychosis patients: a meta-analysis of differential effects of antipsychotic medications.

Authors:  Cenk Tek; Suat Kucukgoncu; Sinan Guloksuz; Scott W Woods; Vinod H Srihari; Aniyizhai Annamalai
Journal:  Early Interv Psychiatry       Date:  2015-05-12       Impact factor: 2.732

Review 6.  Melatonin: an overlooked factor in schizophrenia and in the inhibition of anti-psychotic side effects.

Authors:  George Anderson; Michael Maes
Journal:  Metab Brain Dis       Date:  2012-04-25       Impact factor: 3.584

7.  Cardiovascular mortality in schizophrenia: defining a critical period for prevention.

Authors:  Vinod H Srihari; Vivek H Phutane; Banu Ozkan; Lydia Chwastiak; Joseph C Ratliff; Scott W Woods; Cenk Tek
Journal:  Schizophr Res       Date:  2013-02-17       Impact factor: 4.939

Review 8.  Associations between health risk behaviors and symptoms of schizophrenia and bipolar disorder: a systematic review.

Authors:  Joseph M Cerimele; Wayne J Katon
Journal:  Gen Hosp Psychiatry       Date:  2012-10-06       Impact factor: 3.238

9.  Life expectancy at birth for people with serious mental illness and other major disorders from a secondary mental health care case register in London.

Authors:  Chin-Kuo Chang; Richard D Hayes; Gayan Perera; Mathew T M Broadbent; Andrea C Fernandes; William E Lee; Mathew Hotopf; Robert Stewart
Journal:  PLoS One       Date:  2011-05-18       Impact factor: 3.240

10.  Mortality after hospital discharge for people with schizophrenia or bipolar disorder: retrospective study of linked English hospital episode statistics, 1999-2006.

Authors:  Uy Hoang; Robert Stewart; Michael J Goldacre
Journal:  BMJ       Date:  2011-09-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.